Skip to main content
    N

    Novocure Ltd (NVCR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $11.14
    -0.16 (-1.42%)

    Market Cap: $1.38B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Novocure Ltd (NVCR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Novocure (NVCR) has a latest price of $11.14 on Nov 17, 2026, 48.1% below its 52-week high of $21.45. Its price fell 1.6% over the past 12 months. The month-end price rose 117.4% over the 10 years through Oct 2026, a compound annual rate of 8.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $221.82 in Jun 2021 and its lowest $6.05 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NVCR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVCR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 38.8%, and over 6 months it fell 34.5%. The month-end price fell 1.1% over the 3 years through Oct 2026, a compound annual decline of 0.4%.

    PeriodChange
    1 month-25.2%
    3 months-38.8%
    6 months-34.5%
    12 months-1.6%
    12 months, with dividends-1.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-1.1%-0.4%
    5 years-87.2%-33.7%
    10 years+117.4%+8.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 157.3%, and its weakest was 2023, when it fell 79.6%.

    YearCloseChange
    2026 through Oct 2026$13.15+1.7%
    2025$12.93-56.6%
    2024$29.80+99.6%
    2023$14.93-79.6%
    2022$73.35-2.3%
    2021$75.08-56.6%
    2020$173.04+105.3%
    2019$84.27+151.7%
    2018$33.48+65.7%
    2017$20.20+157.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 23.6% below its 50-day average of $14.59 and 24.6% below its 200-day average of $14.78.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$11.14
    52-week high$21.45-48.1%
    52-week low$9.82+13.4%
    50-day average$14.59-23.6%
    200-day average$14.78-24.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 70.0%.

    MeasureValue
    1-year beta1.52
    Largest fall, 1 year-44.3%
    Largest fall, 3 years-70.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NVCR

    What is NVCR's 1-year price change?

    Novocure's price fell 1.6% over the past 12 months. With dividends included, the 12-month total return was -1.6%.

    What is NVCR's 5-year price change?

    Novocure's month-end price fell 87.2% over the 5 years through Oct 2026, a compound annual decline of 33.7%. These figures leave out dividends.

    What is NVCR's 52-week high and low?

    Novocure's 52-week high is $21.45 and its 52-week low is $9.82. Its latest price of $11.14 on Nov 17, 2026 is 48.1% below the high.

    What is NVCR's beta?

    Novocure's 1-year beta against the S&P 500 is 1.52, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 44.3%.

    Is the NVCR chart free?

    Yes. Advanced Charting for NVCR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.